UK pharma major GSK and private French biotech Syndivia company, which is focused on next-generation antibody-drug conjugate ...

Yesterday, GSK added a new antibody-drug conjugate to its cancer pipeline via a $358 million agreement with French biotech ...

Incyte axed three prospects to focus on “high-value programs,” its CEO said. Elsewhere, MapLight priced an IPO during the ...

Construction crews are in the process of building a 450,000 square foot paper mill that will manufacture 100% recycled products.

The 8pm news from France2 takes an in-depth look at the economic, environmental, political and societal issues of France and the world. In French, no subtitles, delivered via Satellite. Watch on SBS ...